Treatment of Presumed Hyperkalemia in the Prehospital Setting

Robert McArthur1, Zubaid Rafique1, Brad Ward2

  • 1Baylor College of Medicine, Department of Emergency Medicine, Houston, TexasUSA.

Insights

Prehospital treatment for hyperkalemia (HK) is feasible for emergency medical services (EMS). This novel protocol effectively identified and managed presumed HK, with no adverse events during transport.

Area of Science:

  • Emergency Medicine
  • Cardiology
  • Clinical Research

Background:

  • Hyperkalemia (HK) is a common, life-threatening condition that can lead to ventricular arrhythmia and cardiac arrest if untreated.
  • Early intervention for HK significantly reduces mortality rates.

Purpose of the Study:

  • To evaluate a novel protocol for the identification and empiric management of presumed hyperkalemia in the prehospital setting.
  • To assess the feasibility and safety of this protocol for Emergency Medical Services (EMS) crews.

Main Methods:

  • Retrospective observational chart review of patients treated for presumed HK with clinical concern and ECG changes.
  • Inclusion criteria: patients treated for presumed HK with ECG changes, excluding those in cardiac arrest on arrival.
  • Empiric treatment included calcium, sodium bicarbonate, and albuterol; adverse events and serum potassium levels were recorded.

Main Results:

  • 48 patients were included in the analysis; 45.8% had serum potassium >5.0 mEq/L.
  • 89.6% of cases showed hyperkalemia-related ECG changes.
  • No episodes of unstable tachyarrhythmia or cardiac arrest occurred during EMS treatment or transport.

Conclusions:

  • The novel prehospital protocol for identifying and managing presumed HK is feasible for EMS crews.
  • Further research with a larger study population is necessary to generalize these findings.
Abstract

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
66
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
727
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
24
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
104
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
149